Author
Listed:
- Luis E. Santos
(D’Or Institute for Research and Education (IDOR))
- Paulo Mattos
(D’Or Institute for Research and Education (IDOR)
Federal University of Rio de Janeiro
Federal University of Rio de Janeiro)
- Thais L. Pinheiro
(D’Or Institute for Research and Education (IDOR))
- Ananssa Silva
(D’Or Institute for Research and Education (IDOR))
- Claudia Drummond
(D’Or Institute for Research and Education (IDOR)
Federal University of Rio de Janeiro)
- Felipe Kenji Sudo
(D’Or Institute for Research and Education (IDOR))
- Fernanda Barros-Aragão
(D’Or Institute for Research and Education (IDOR))
- Bart Vanderborght
(D’Or Institute for Research and Education (IDOR))
- Carlos Otávio Brandão
(Neurolife – Cerebrospinal Fluid Specialized Laboratory)
- Sergio T. Ferreira
(D’Or Institute for Research and Education (IDOR)
Federal University of Rio de Janeiro
Federal University of Rio de Janeiro)
- Fernanda Tovar-Moll
(D’Or Institute for Research and Education (IDOR))
- Fernanda G. Felice
(D’Or Institute for Research and Education (IDOR)
Federal University of Rio de Janeiro
Queen’s University)
Abstract
Despite remarkable progress in the biomarker field in recent years, local validation of plasma biomarkers of Alzheimer’s disease (AD) and dementia is still lacking in Latin America. In this longitudinal cohort study of 145 elderly Brazilians, we assess the diagnostic performance of plasma biomarkers, based on clinical diagnosis and CSF biomarker positivity. Follow-up data of up to 4.7 years were used to determine performance in predicting diagnostic conversions. Participants were clinically categorized as cognitively unimpaired (n = 49), amnestic mild cognitive impairment (n = 29), AD (n = 38), Lewy body dementia (n = 22), or vascular dementia (n = 7). Plasma Tau, Aβ40, Aβ42, NfL, GFAP, pTau231, pTau181 and pTau217 were measured on the SIMOA HD-X platform. Plasma pTau217 showed excellent performance determining CSF biomarker status in the cohort, either alone (ROC AUC = 0.94, 95% CI: [0.88–1.00]) or as a ratio to Aβ42 (ROC AUC = 0.98, 95% CI: [0.94–1.00]). This study comprises an initial step towards local validation and adoption of dementia biomarkers in Brazil.
Suggested Citation
Luis E. Santos & Paulo Mattos & Thais L. Pinheiro & Ananssa Silva & Claudia Drummond & Felipe Kenji Sudo & Fernanda Barros-Aragão & Bart Vanderborght & Carlos Otávio Brandão & Sergio T. Ferreira & Fer, 2025.
"Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort,"
Nature Communications, Nature, vol. 16(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56756-3
DOI: 10.1038/s41467-025-56756-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56756-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.